QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=244207C3A3FCEEC9DABDE2D4892A3F6B;jsessionid=8D74CC26DCC95218CC2BB8B76EB22CAC;jsessionid=DAC94F3400E3CB8DB8FCBAE9C00D9A04;jsessionid=5F16A3AB4FF2F3DE227797458CC7E2C0;jsessionid=E99F2C2E4897AD8F8CF26EFE27556F04;jsessionid=46CB8D452F74B7EBCAE3FC61D080A3AD;jsessionid=AB21ACEC07747E69C7DD5AEF014C9F97;jsessionid=C5F82D4BC68F50FC7770203BB1C01B36 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=244207C3A3FCEEC9DABDE2D4892A3F6B;jsessionid=8D74CC26DCC95218CC2BB8B76EB22CAC;jsessionid=DAC94F3400E3CB8DB8FCBAE9C00D9A04;jsessionid=5F16A3AB4FF2F3DE227797458CC7E2C0;jsessionid=E99F2C2E4897AD8F8CF26EFE27556F04;jsessionid=46CB8D452F74B7EBCAE3FC61D080A3AD;jsessionid=AB21ACEC07747E69C7DD5AEF014C9F97;jsessionid=C5F82D4BC68F50FC7770203BB1C01B36